Company CVAbout Murae Organisor Ltd 
Murae Organisor Ltd
Small Cap
Pharmaceuticals & Biotechnology
Murae Organisor Limited was originally incorporated as "Earum Pharmaceuticals Private Limited" on July 26, 2012 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, Company was converted into a Public Limited and the name of Company was changed to "Earum Pharmaceuticals Limited" vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 185.90 Cr
Number of Shares
185.9 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Jun-2025
185.9
185.90
929482155
1
Stock Split
19-Dec-2024
92.95
185.90
232370539
2
Right Issues
10-Apr-2023
24.71
49.42
185432518
2
Right Issues
16-Dec-2021
6.17
12.34
49343280
2
Stock Split
09-Aug-2021
1.23
12.34
6167910
10
Bonus Issue
04-Jul-2019
61.68
6.17
1848000
10
Public Issues
02-Jul-2019
61.68
6.17
1848000
10
Public Issue
09-Apr-2019
43.2
4.32
4011345
10
Bonus Issue
21-Feb-2018
3.09
0.31
137140
10
further allotment
02-Jun-2017
1.71
0.17
64000
10
further allotment
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
None
Highest Public shareholder
Ifl Enterprises Limited (6.38%)
Individual Investors Holdings
75.04%
Board of Directors
Management
Designation
Remuneration
Bhumishth Narendrabhai Patel
Chairman & Managing Director
0
Bhumishth Narendrabhai Patel
Non Executive Director
0
Payal Bhumishth Patel
Whole Time Director & CFO
0
Bhavik Shantilal Patel
Independent Director
0
Dahyabhai Mafatlal Patel
Addtnl Non-Executive Director
0
Parimal S Patwa
Addtnl Independent Director
0
Harsh M Kothari
Addtnl Independent Director
0
Madhuri Mistry
Company Sec. & Compli. Officer
0
Sumitkumar Patel
Independent Director
0
Premaram Patel
Additional Director
0
Sanjaykumar Nai
Additional Director
0
Vijaykumar Patel
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Formulation Products - Traded
35.44
100.00%
Pharmaceutical Formulation Products - Traded
Stock DNARevenue and Profits:
Net Sales:
4 Cr
(Quarterly Results - Jun 2025)
Net Profit:
7 Cr
Pharmaceuticals & Biotechnology
INR 55 Cr (Small Cap)
4.00
34
0.00%
0.80
7.29%
0.26
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
